Aller au contenu principal
SWEDEN

AN AMBITIOUS NEW ROADMAP UP TO 2028

Since its stock market listing in May 2006, Arkema has deeply transformed its profile, strengthening its competitiveness and refocusing its activities on specialty activities. As a leading player in Specialty Materials, Arkema has a unique portfolio of cutting-edge technologies, well positioned to capture opportunities linked to global megatrends.

On the strength of this strategic repositioning and its more robust profile, Arkema unveiled a new phase in its evolution at the Capital Markets Day in September 2023, which will focus primarily on organic growth.

Thus the Group aims at achieving sales of around €12 billion by 2028, supported by organic growth of 4% per year over the 
2024-28 period, and an EBITDA margin of around 18%. Organic growth in EBITDA is expected to average 7% to 8% per year over the same period.

To successfully carry out this new phase, the Group intends to use several levers:

  • LEVERAGE the strength of One Arkema.
  • ACHIEVE superior growth from sustainable innovation in key technologies and markets.
  • RAMP UP recent major capex and carry out new, targeted high-return projects.
  • FURTHER STRENGTHEN the portfolio with bolt-on M&A and finalize the divestment of Intermediates.
  • DRIVE our manufacturing excellence, including a strong focus on decarbonization and digitalization.

THE DRIVERS

Leverage the strength of One Arkema

Through the One Arkema culture, employees from different Business Lines share their expertise to develop significant technological, industrial and commercial synergies within the Group, enabling to amplify the strength of Arkema’s three Specialty Materials segments.

To successfully implement this new growth phase, the Group, leveraging the strengths of One Arkema, is implementing strong initiatives aimed at increasing customer proximity, in particular through a network of global key account managers and the development of more targeted and effective digital tools such as the My.Arkema customer portal and the ‘Sales Academy program designed to improve our sales teams’ productivity and agility.

Achieve superior growth from sustainable innovation in key technologies and markets

Within its end markets, the Group has identified five key high-growth markets driven by global megatrends and are expected to grow at a faster pace: green energy and electric mobility, advanced electronics, sustainable lifestyle, efficient buildings and homes, and various niche markets in water, medical and crop nutrition.

Over time, through innovation, investments and acquisitions, Arkema has built a unique portfolio of high-performance technologies that are essential to these 5 key markets, accounting for 15% of its sales in 2023.

Thanks to the versatility of these technologies, the Group can maximize development and growth opportunities, drawing on the strength of the shared One Arkema approach. The Group will allocate more than half of its R&D expenditure to these 5 key markets, and will rely on more than 1,800 researchers at 17 research centres worldwide to develop new products, applications and production technologies in order to meet the particularly demanding needs of its customers and support them in their quest for sustainable performance.

Ramp up major recent capex and carry out new, targeted high-return projects

To achieve its growth objective over the 2024-28 period, Arkema will leverage in particular the start-up of its recent projects, which include new 
bio-based PA11 units in Asia, the development of PVDF in China and France, Sartomer resins in China and Pebax in France, as well as projects in fluorospecialities in the USA, namely the supply of HF in partnership with Nutrien and the new 1233zd unit.

Over the 2024-28 period, the Group will continue its ambitious investment policy, in particular in high-growth markets, and plans to devote around 55% of available cash to its capital expenditure program, a little over half of which will be used for growth investments. Three attractive new projects have already been announced: the new DMDS unit in the USA for the biofuels market, the decarbonization of acrylics production in France, and the extension of the organic peroxides site in China. Other projects are still being examined, in battery solutions in the USA and in the bio-based PA11 value chain.

Further strengthen the portfolio with targeted acquisitions and finalize the divestment of intermediates.

Since 2006, Arkema has made active portfolio management a major transformation lever and notably aims, by 2028, to continue to make bolt-on acquisitions that will strengthen its portfolio of technologies, particularly in the 5 high-growth markets identified by the Group and in the fragmented adhesives sector. Moreover, Arkema also plans to deconsolidate its Intermediates activities.

Among the most recent transactions, Arkema made a major acquisition in Advanced Materials with the acquisition of a 54% majority stake in PI Advanced Materials (PIAM), the world leader in polyimide film used in the attractive mobile phone and electric vehicle markets.

Develop operational excellence initiatives with a strong focus on decarbonization and digitalization

The Group aims to ensure the competitiveness and sustainability of its production sites around the world, through strong initiatives in the area of operational excellence. Arkema’s ambition is notably to reduce its annual operating expenditure by €250 million by 2028. This approach goes hand in hand with clearly defined and ambitious objectives for each production site in terms of safety and the environment, reliability, productivity and use of raw materials, combined with fine-tuned management of improvement plans. The Group will pay particular attention to accelerating the digitalization, automation and streamlining of processes, while continuing to enhance the reliability of its industrial facilities.

Lastly, Arkema will continue to reduce its environmental footprint, in particular by implementing its decarbonization trajectory. In May 2023, the Group set ambitious new targets across its entire value chain. These targets, aligned with a ‘1.5°C trajectory by 2030’ approach and validated by the SBTi (Science Based Targets initiative) organization, pave the way for Net-Zero by 2050.

  • €9.5 billion in sales*
  • 21,100 employees*
  • 55 countries*
  • 151 factories around the world*
  • €275 million invested in R&D*

* Results as of 12/31/2023 available at https://www.arkema.com/global/en/arkema-group/profile

Back to top